Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ YhglL!p
C
,e$RvFB
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© `m1stK(PO
;(,GS@
sP
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© X)]>E]X
p=[dt
1.Co-stimulators (or co-stimulating molecules) IuPDr %
o+OX^F0
2.NK-kB .Sw4{m[g
N0lFx?4
3.Immunoglobulin superfamily YVRE9
jyg>'"W
4.antigen-presenting cell (APC) oIE(`l0l
"AJ>pU3
5.death domain Jp)PKS
![
Jnt
r"a-4
6.CCR and CXCR -$s1k~o
-{eiV0<^
7.Lectin (or mitogen) /s)It
_jkJw2+s\
8.Clusters of differentiation, CD) ioTqT:.
&U.y):
9.B7 family ,,9vk \
nYRD>S?uz
10.Cytotoxic T lymphocyte, CTL) g5Hsz,x
S9/\L6Rmf
11.IL-15 and IL-15 receptor (IL-15R) P#A|Pn<p
~;I{d7z,;
12.MHC restriction i3Nt?FSN
t.O4-+$ig
13.Affinity-chromatography >273V+dy
1^;&?E
14.Cyctosprin A, CsA xi\uLu?i
6B?1d
/8V
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) v#IZSBvuQK
Ox/va]e7"
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© v:j4#pEWD
Sag\wKV8
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 tQ?}x#J
' :]
w
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ b}q,cm
aR;Q^YJ+a
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 b}G +7B
X]CaWxM
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© *JOv
4 ]8PF
ÃâÒßѧרҵ£º kQBVx8Uq]
tv|=`~Y
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ J5rR?[i{
_H3cqD
Ïû»¯ÄÚ¿Æ£º ?,),%JQ
L_Ai/'
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ $S cjEG:6
&k{@:z
ѪҺ²¡Ñ§×¨Òµ£º B'0Il"g'
(}qLxZ/U
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿